Flow cytometric immunophenotyping in posttransplant lymphoproliferative disorders

Area of Science:

• Transplant Medicine
• Hematopathology
• Immunology

Background:

• Posttransplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of lymphoid proliferations.
• Accurate classification of PTLDs is crucial for patient management and prognosis.
• Distinguishing reactive lymphoid hyperplasias from PTLDs often relies on demonstrating clonality.

Purpose of the Study:

• To evaluate the utility of flow cytometric immunophenotyping (FCI) and genotypic studies (GS) in characterizing PTLDs.
• To compare the sensitivity of FCI and GS in detecting B-cell clonality in various PTLD categories.
• To determine the combined diagnostic value of FCI and GS for PTLD assessment.

Main Methods:

• Analysis of 11 PTLD specimens from 10 transplant recipients.
• Flow cytometric immunophenotyping (FCI) to assess B-cell immunophenotypes and identify aberrant or monoclonal populations.
• Genotypic studies (GS), including polymerase chain reaction and/or Southern blot, for T-cell and B-cell gene rearrangements (BGR).

Main Results:

• FCI identified monoclonal or aberrant B cells in most PTLDs, including polymorphic B-cell lymphomas (PBCLs), immunoblastic lymphomas, and multiple myelomas.
• Genotypic studies detected B-cell gene rearrangements (BGR) in a subset of cases.
• FCI identified clonality in PTLDs negative by GS, while one PBCL showed discordance (polyclonal by FCI, monoclonal by GS).

Conclusions:

• Flow cytometric immunophenotyping (FCI) is valuable for detecting clonal processes in PTLDs, particularly when genotypic studies (GS) are negative.
• FCI and GS should be routinely performed in PTLD diagnosis to enhance the detection of clonal lymphoid proliferations.
• The combination of FCI and GS offers a comprehensive approach to PTLD characterization.